Research ExplorerPublicationsS2-Leitlinie zur Diagnostik und Therapie der sekundären Eise...

S2-Leitlinie zur Diagnostik und Therapie der sekundären Eisenüberladung bei Patienten mit angeborenen Anämien

Standard

S2-Leitlinie zur Diagnostik und Therapie der sekundären Eisenüberladung bei Patienten mit angeborenen Anämien. / Cario, H; Grosse, R; Janssen, G; Jarisch, A; Meerpohl, J; Strauss, G; German hematology societies (GPOH and DGHO).

In: KLIN PADIATR, Vol. 222, No. 6, 6, 11.2010, p. 399-406.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Cario, H, Grosse, R, Janssen, G, Jarisch, A, Meerpohl, J, Strauss, G & German hematology societies (GPOH and DGHO) 2010, 'S2-Leitlinie zur Diagnostik und Therapie der sekundären Eisenüberladung bei Patienten mit angeborenen Anämien', KLIN PADIATR, vol. 222, no. 6, 6, pp. 399-406. https://doi.org/10.1055/s-0030-1265178

APA

Cario, H., Grosse, R., Janssen, G., Jarisch, A., Meerpohl, J., Strauss, G., & German hematology societies (GPOH and DGHO) (2010). S2-Leitlinie zur Diagnostik und Therapie der sekundären Eisenüberladung bei Patienten mit angeborenen Anämien. KLIN PADIATR, 222(6), 399-406. [6]. https://doi.org/10.1055/s-0030-1265178

Vancouver

Cario H, Grosse R, Janssen G, Jarisch A, Meerpohl J, Strauss G et al. S2-Leitlinie zur Diagnostik und Therapie der sekundären Eisenüberladung bei Patienten mit angeborenen Anämien. KLIN PADIATR. 2010 Nov;222(6):399-406. 6. https://doi.org/10.1055/s-0030-1265178

Bibtex

@article{11b58ca26a5e4d708cf2a36ff684f9df,
title = "S2-Leitlinie zur Diagnostik und Therapie der sekund{\"a}ren Eisen{\"u}berladung bei Patienten mit angeborenen An{\"a}mien",
abstract = "In Germany and Central Europe, congenital disorders leading to secondary hemochromatosis are rare. The majority of these patients are treated in peripheral medical institutions. As a consequence, the experience of each institution in the treatment of secondary hemochromatosis in patients with congenital anemia is limited. Recent developments concerning new chelating agents, their combination for intensified chelation and new possibilities to diagnose and monitor iron overload have important consequences for the management of patients with secondary hemochromatosis and increase its complexity enormously. Therefore, the development of a guideline for rational and efficient diagnostics and treatment was necessary. The new guideline was developed within a formal consensus process and finally approved by a consensus conference with participants from both the pediatric and adult German hematology societies (GPOH and DGHO). Apart from general information and recommendations, the guideline contains 9 consensus statements on diagnostics (iron status, siderotic complications, chelator side-effects), the start of chelation, indications for intensified chelation, iron elimination in specific disorders, and iron elimination after stem cell transplantation. Here, these consensus statements are presented and discussed in detail. For the complete text of the guideline, please visit the AWMF homepage at http://www.leitlinien.net .",
keywords = "Anemia, Aplastic, Anemia, Diamond-Blackfan, Anemia, Dyserythropoietic, Congenital, Anemia, Sickle Cell, Chelating Agents, Child, Deferoxamine, Erythrocyte Transfusion, Ferritins, Germany, Hematopoietic Stem Cell Transplantation, Hemochromatosis, Hemosiderosis, Humans, beta-Thalassemia",
author = "H Cario and R Grosse and G Janssen and A Jarisch and J Meerpohl and G Strauss and {German hematology societies (GPOH and DGHO)}",
note = "{\textcopyright} Georg Thieme Verlag KG Stuttgart · New York.",
year = "2010",
month = nov,
doi = "10.1055/s-0030-1265178",
language = "Deutsch",
volume = "222",
pages = "399--406",
journal = "KLIN PADIATR",
issn = "0300-8630",
publisher = "Georg Thieme Verlag KG",
number = "6",

}

RIS

TY - JOUR

T1 - S2-Leitlinie zur Diagnostik und Therapie der sekundären Eisenüberladung bei Patienten mit angeborenen Anämien

AU - Cario, H

AU - Grosse, R

AU - Janssen, G

AU - Jarisch, A

AU - Meerpohl, J

AU - Strauss, G

AU - German hematology societies (GPOH and DGHO)

N1 - © Georg Thieme Verlag KG Stuttgart · New York.

PY - 2010/11

Y1 - 2010/11

N2 - In Germany and Central Europe, congenital disorders leading to secondary hemochromatosis are rare. The majority of these patients are treated in peripheral medical institutions. As a consequence, the experience of each institution in the treatment of secondary hemochromatosis in patients with congenital anemia is limited. Recent developments concerning new chelating agents, their combination for intensified chelation and new possibilities to diagnose and monitor iron overload have important consequences for the management of patients with secondary hemochromatosis and increase its complexity enormously. Therefore, the development of a guideline for rational and efficient diagnostics and treatment was necessary. The new guideline was developed within a formal consensus process and finally approved by a consensus conference with participants from both the pediatric and adult German hematology societies (GPOH and DGHO). Apart from general information and recommendations, the guideline contains 9 consensus statements on diagnostics (iron status, siderotic complications, chelator side-effects), the start of chelation, indications for intensified chelation, iron elimination in specific disorders, and iron elimination after stem cell transplantation. Here, these consensus statements are presented and discussed in detail. For the complete text of the guideline, please visit the AWMF homepage at http://www.leitlinien.net .

AB - In Germany and Central Europe, congenital disorders leading to secondary hemochromatosis are rare. The majority of these patients are treated in peripheral medical institutions. As a consequence, the experience of each institution in the treatment of secondary hemochromatosis in patients with congenital anemia is limited. Recent developments concerning new chelating agents, their combination for intensified chelation and new possibilities to diagnose and monitor iron overload have important consequences for the management of patients with secondary hemochromatosis and increase its complexity enormously. Therefore, the development of a guideline for rational and efficient diagnostics and treatment was necessary. The new guideline was developed within a formal consensus process and finally approved by a consensus conference with participants from both the pediatric and adult German hematology societies (GPOH and DGHO). Apart from general information and recommendations, the guideline contains 9 consensus statements on diagnostics (iron status, siderotic complications, chelator side-effects), the start of chelation, indications for intensified chelation, iron elimination in specific disorders, and iron elimination after stem cell transplantation. Here, these consensus statements are presented and discussed in detail. For the complete text of the guideline, please visit the AWMF homepage at http://www.leitlinien.net .

KW - Anemia, Aplastic

KW - Anemia, Diamond-Blackfan

KW - Anemia, Dyserythropoietic, Congenital

KW - Anemia, Sickle Cell

KW - Chelating Agents

KW - Child

KW - Deferoxamine

KW - Erythrocyte Transfusion

KW - Ferritins

KW - Germany

KW - Hematopoietic Stem Cell Transplantation

KW - Hemochromatosis

KW - Hemosiderosis

KW - Humans

KW - beta-Thalassemia

U2 - 10.1055/s-0030-1265178

DO - 10.1055/s-0030-1265178

M3 - SCORING: Zeitschriftenaufsatz

C2 - 20862634

VL - 222

SP - 399

EP - 406

JO - KLIN PADIATR

JF - KLIN PADIATR

SN - 0300-8630

IS - 6

M1 - 6

ER -